Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
MPLA Synthetic VacciGrade™ Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity. 2017 Cell. Israel L. et al. DOI: 10.1016/j.cell.2017.01.039
SB203580 A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens. 2017 J Clin Invest. Sindhava V.J. et al. DOI: 10.1172/JCI89931
Anti-hTLR6 Neutralizing mAb Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6. 2017 Immunol Cell Biol. Modhiran N. et al. DOI: 10.1038/icb.2017.5
Hygromycin B Gold Virion-independent transfer of replication-competent hepatitis C virus RNA be... 2015 J Virol. Longatti A. et al. DOI: 10.1128/JVI.02721-14
LPS-SM Ultrapure (LPS from S. minnesota R595) Defective lymphoid organogenesis underlies the immune deficiency caused by a ... 2015 J Exp Med. Mooster J.L. et al. DOI: 10.1084/jem.20140979
c-di-AMP VacciGrade™ IFI16 and cGAS cooperate in the activation of STING during DNA sensing in hum... 2017 Nat Commun. Almine J.F. et al. DOI: 10.1038/ncomms14392
Zymosan Depleted Neuroinflammation triggered by β-glucan/dectin-1 signaling enables CNS axon r... 2015 PNAS Baldwin K.T. et al. DOI: 10.1073/pnas.1423221112
ODN 1668 - TLR9 ligand Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression. 2014 Cancer Res. Guery L. et al. DOI: 10.1371/journal.pone.0093362
Anti-CD20 (Rituximab biosimilar - mIgG1 isotype) Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibo... 2013 Science. Weiskopf K. et al. 341(6141):88-91.
TLR4-based adjuvant - MPLA-SM VacciGrade™ The Cytokine Response to Lipopolysaccharide Does Not Predict the Host Respons... 2017 J Immunol. Fensterheim B.A. et al. DOI: 10.4049/jimmunol.1602106
LPS-RS Soluble CD14 acts as a DAMP in human macrophages: origin and involvement in i... 2017 FASEB J. Lévêque M. et al. DOI: 10.1096/fj.201600772R
RAW-Blue™ Cells Glucosylation Drives the Innate Inflammatory Response to Clostridium difficil... 2016 Infect Immun. Cowardin C.A. et al. DOI: 10.1128/IAI.00327-16
ssRNA40/LyoVec™ B. abortus RNA is the component involved in the down-modulation of MHC-I expr... 2017 PLoS Pathog. Milillo M.A. et al. DOI: 10.1371/journal.ppat.1006527
Murabutide Advax-Adjuvanted Recombinant Protective Antigen Provides Protection against I... 2014 Clin Vaccine Immunol. Feinen B. et al. DOI: 10.1128/CVI.00019-14
pVITRO1-MCS Characterization of vitamin K–dependent carboxylase mutations that cause blee... 2016 Blood Tie JK. et al. DOI: 10.1182/blood-2015-10-677633
ASC Knockout & Knockdown Monocytes Extracellular Ca(2+) is a danger signal activating the NLRP3 inflammasome thr... 2012 Nat Commun. Rossol M. et al. DOI: 10.1038/ncomms2339
Plasmocure™ - Mycoplasma Elimination Reagent An NLRP7-containing inflammasome mediates recognition of microbial lipopeptid... 2012 Immunity Khare S. et al. DOI: 10.1016/j.immuni.2012.02.001
Normocin® - Antimicrobial Reagent CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment... 2016 Cancer Res. Chang A.L. et al. DOI: 10.1158/0008-5472.CAN-16-0144
DNA synthesis inhibitor Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosupp... 2014 Cancer Cell. Özdemir B.C. et al. DOI: 10.1016/j.ccr.2014.04.005
Human TLR9 Reporter HEK293 Cells (NF-κB) Investigations on the molecular mode of action of the novel immunostimulator ... 2017 Mol Immunol. Ilg T. DOI: 10.1016/j.molimm.2017.07.013

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty